← back to search

Wieneke A. Buikhuisen

The Netherlands Cancer Institute ·
Area of research
Epidemiology · Oncology
Research interest
Research interests include Neuroendocrine Tumor Research Advances, Lung Cancer Research Studies, Neuroblastoma Research and Treatments, and Occupational and environmental lung diseases.
h-index
21
citations
1,853
works
60
NIH funding
primary concept
Medicine
email

Recent publications

Treatment of advanced BP-NETS with lanreotide autogel/depot vs placebo: the phase III SPINET study
Endocrine Related Cancer 2024cited by 24position: middledoi
Druggable growth dependencies and tumor evolution analysis in patient-derived organoids of neuroendocrine neoplasms from multiple body sites
Cancer Cell 2023cited by 75position: middledoi
Systematic and combined endosonographic staging of lung cancer (SCORE study)
European Respiratory Journal 2018cited by 88position: middledoi
Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial
The Lancet Oncology 2015cited by 220position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Hilary Calvert · Newcastle University1 papers (2015–2015) · 1 papers (2024–2024)Ruth Plummer · Sir Bobby Robson Foundation1 papers (2015–2015) · 1 papers (2024–2024)Sayed M.S. Hashemi · Amsterdam Neuroscience1 papers (2018–2018)Anne S. Tsao · The University of Texas MD Anderson Cancer Center1 papers (2015–2015)Éric Baudin · Institut Gustave Roussy1 papers (2024–2024)Wilfried Eberhardt · Deutschen Konsortium für Translationale Krebsforschung1 papers (2015–2015) · 1 papers (2018–2018) · 1 papers (2018–2018) · 1 papers (2015–2015)Dieter Hörsch · Zentralklinik Bad Berka1 papers (2024–2024)Hedy L. Kindler · Public Health Ontario1 papers (2015–2015) · 1 papers (2018–2018)Simron Singh · Sunnybrook Health Science Centre1 papers (2024–2024)Xing Sun · Hebei Medical University1 papers (2015–2015) · 1 papers (2018–2018)Éric Dansin · Centre Oscar Lambret1 papers (2024–2024)Lee M. Krug · AstraZeneca (Switzerland)1 papers (2015–2015) · 1 papers (2015–2015)